Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Aim: To investigate the effect of key tissue culture conditions on cell growth, gene expression and functional uptake of peptide and organic cation transporter substrates in the human nasal epithelium (HNE). Methods: HNE were cultured on different growth surfaces (polystyrene plastic, collagen film, and hydrated collagen gel) and were maintained with three popular nasal tissue culture media supplements [DMEM/F12 supplemented with Ultroser® G (2%), FBS (10%) and NuSerum® (10%)], respectively. The expression of gene transcripts for organic cation and peptide transporters were screened using qPCR and substrate uptake studies. Results: Cell growth surface (polystyrene plastic surface, dried collagen film and hydrated collagen gel) did not significantly alter gene expression levels. However, Ultroser ® G and FBS caused significant increase in PEPT1, PEPT2, PHT1, OCT3, and OCTN1 levels (≅2-5-fold for FBS and 2-8-fold for Ultroser ® G). In terms of the degree to which the supplements affected gene expression, the following observations were made: effect on OCTN1 > PEPT2 > OCT3 > PHT1 > PEPT1. Functional uptake of organic cation (4-Di-1-ASP) and peptide [β-Ala-Lys (AMCA)] transporter substrates was significantly lower in cells cultured with NuSerum® compared to Ultroser® G and FBS cultured cells (p > 0.05). Conclusions: Tissue culture media had a major effect on SLC gene expression levels of the human nasal epithelium in primary culture. Ultroser® G was identified as the most efficient culture supplement in maintaining SLC transporter expression under most culture conditions, whereas FBS appears to be an economical choice. We do not recommend the use of NuSerum® as a supplement for growing HNE for transport studies involving SLC transporters.

Original languageEnglish
Pages (from-to)334-342
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume441
Issue number1-2
DOIs
Publication statusPublished - Jan 30 2013

Bibliographical note

Funding Information:
We thank Caren Wyse for liaison between QEII hospital and our laboratory, and Dr. Kerry Goralski for PCR instrumentation. Funding for this project was provided by Nova Scotia Health Research Foundation (MED-Project- 2008-4691 ).

ASJC Scopus Subject Areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro'. Together they form a unique fingerprint.

Cite this